| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 732.31B | 660.26B | 609.01B | 554.55B | 560.12B |
| Gross Profit | 411.66B | 349.25B | 293.11B | 238.75B | 245.94B |
| EBITDA | 302.54B | 310.14B | 183.94B | 134.30B | 313.65B |
| Net Income | 219.02B | 194.07B | 115.22B | 188.24B | 224.82B |
Balance Sheet | |||||
| Total Assets | 2.04T | 1.79T | 1.58T | 1.56T | 1.61T |
| Cash, Cash Equivalents and Short-Term Investments | 433.92B | 341.57B | 375.91B | 288.13B | 264.35B |
| Total Debt | 406.57B | 357.94B | 370.14B | 354.07B | 322.89B |
| Total Liabilities | 798.26B | 733.37B | 708.09B | 788.90B | 735.46B |
| Stockholders Equity | 1.15T | 973.07B | 806.20B | 711.20B | 804.85B |
Cash Flow | |||||
| Free Cash Flow | 190.17B | 181.76B | 174.56B | 95.24B | 113.02B |
| Operating Cash Flow | 303.05B | 258.52B | 221.96B | 146.09B | 175.19B |
| Investing Cash Flow | -205.73B | -122.19B | -125.16B | -104.87B | -178.55B |
| Financing Cash Flow | -87.16B | -176.49B | -82.57B | -59.95B | 21.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$190.98B | 13.56 | 25.52% | ― | 12.62% | 22.16% | |
72 Outperform | HK$4.46T | 22.32 | 19.90% | 0.75% | 13.92% | 18.31% | |
72 Outperform | HK$105.63B | 17.65 | 13.77% | 1.01% | 15.94% | 69.62% | |
65 Neutral | HK$16.14B | -128.76 | 12.13% | 8.13% | 0.06% | 48.33% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
53 Neutral | HK$335.56B | 59.14 | 1.73% | ― | -3.02% | -81.33% | |
47 Neutral | HK$26.42B | -39.92 | -4.08% | ― | -9.16% | -273.98% |